ARS Pharmaceuticals Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio128.19
P/S Ratio11.5017535.50607.80
P/B Ratio3.992.282.93
Price/Tangible Book4.122.292.93
Price/FCF78.96
Price/OCF75.68
Enterprise Value Ratios
EV/Revenue9.219483.00637.20
EV/FCF63.20
Profitability & Returns
Return on Equity (ROE)0.03%-0.22%-0.22%-0.78%
Return on Assets (ROA)-0.01%-0.16%-0.13%-0.28%
Return on Invested Capital (ROIC)-0.40%-81.35%
Return on Capital Employed (ROCE)-0.01%-0.29%-0.13%-0.36%-0.03%
Leverage & Solvency Ratios
Debt/Equity0.270.000.000.201.40
Debt/FCF5.351.10
Liquidity Ratios
Current Ratio14.2696.9251.017.423.21
Quick Ratio13.7995.8050.597.343.03
Efficiency Ratios
Asset Turnover0.300.000.010.13
Yield & Distribution Ratios
Earnings Yield0.01%-0.10%-0.04%
FCF Yield0.01%-0.11%-0.05%
Buyback Yield-0.08%-1.38%-0.38%-0.43%